P 36 (Pyrazinamide 500 mg)
Pill imprint P 36 has been identified as Pyrazinamide 500 mg.
Pyrazinamide is used in the treatment of tuberculosis, active; tuberculosis, latent and belongs to the drug class miscellaneous antituberculosis agents. Risk cannot be ruled out during pregnancy. Pyrazinamide 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
Pyrazinamide
- Imprint:
- P 36
- Strength:
- 500 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antituberculosis agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dava Pharmaceuticals Inc.
More about pyrazinamide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous antituberculosis agents
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
